- Home
- Speech Language Therapy Review Criteria Guidelines Update
Speech Language Therapy Review Criteria Guidelines Update
This market research, not available anymore on the publisher's website, was withdrawn from our database.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
ImmunoCellular Therapeutics, Ltd. (IMUC) - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- by Global Data
- May 2013
- 34 pages
Summary ImmunoCellular Therapeutics, Ltd. (IMCU) is a clinical-stage biotechnology company. It develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. The company's immunotherapies product ...
Industries: Therapy | Countries: United States
ImmunoCellular Therapeutics, Ltd. (Symbol:IMUC) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- May 2013
- 45 pages
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. ImmunoCellular Therapeutics, Ltd. SWOT Analysis report provides you ...
Industries: Therapy | Countries: United States
Hyperion Therapeutics, Inc. (HPTX) - Financial and Strategic SWOT Analysis Review
- $ 125
- Company report
- by Global Data
- May 2013
- 35 pages
Summary Hyperion Therapeutics, Inc. (Hyperion Therapeutics) is a biopharmaceutical company, which focuses on the development and commercialization of novel drugs for the treatment of orphan diseases and hepatology disorders. Ravicti, the company's first approved product is indicated for use as a nitrogen-binding ...
Industries: Therapy | Countries: United States
Cornerstone Therapeutics Inc. (Symbol:CRTX) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- May 2013
- 39 pages
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Cornerstone Therapeutics Inc. SWOT Analysis report provides you a ...
Industries: Therapy | Countries: United States
Pain Therapeutics, Inc. (Symbol:PTIE) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- May 2013
- 40 pages
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Pain Therapeutics, Inc. SWOT Analysis report provides you a strategic ...
Industries: Therapy
Octapharma AG SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- May 2013
- 27 pages
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...
Industries: Therapy | Countries: Germany
TG Therapeutics, Inc. (TGTX) - Financial and Strategic SWOT Analysis Review
- $ 125
- Company report
- by Global Data
- May 2013
- 35 pages
Summary TG Therapeutics, Inc. (TG Therapeutics), formerly known as Manhattan Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It acquires, develops and commercializes pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The company is developing ...
Industries: Therapy
Personalized Medicine Market Analysis
- $ 1 200
- Industry report
- by RNCOS
- May 2013
- 90 pages
Advancements in the field of genomics have created ample opportunities for personalized medicines to emerge in the healthcare industry. Personalized medicine represents an interface of therapeutics and diagnostics. It involves the tailoring of treatments as per individuals. The growing research applications ...
Industries: Therapy
OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017
- $ 5 995
- Industry report
- by Global Data
- April 2013
- 136 pages
OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017 Summary Idiopathic Pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia of unknown cause. Limited to the lungs it occurs primarily in older adults' =50 years old, with ...
Industries: Therapy
Ascenta Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- by Global Data
- April 2013
- 21 pages
Summary Ascenta Therapeutics, Inc. (Ascenta Therapeutics) is a bio-pharmaceutical company, based in the US. The company discovers and develops medicines for the treatment of cancer. The company focuses on novel, orally-active, small molecule drugs that restores the natural potential for cancer cells ...
Industries: Therapy | Countries: United States
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- 00 1 718 213 49 04
ref:plp2012
Reportlinker.com © Copyright 2013. All rights reserved.
